I kombinationsgruppen var der 4 tilfælde (2%) af progression i centralnervesystemet sammenlignet med 13 tilfælde (6%) af progression i gruppen med capecitabine alene.
On the combination arm, there were 4 (2%) progressions in the central nervous system as compared with the 13 (6%) progressions on the capecitabine alone arm.